AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Jazz Pharmaceuticals plc Director's Dealing 2016

Aug 18, 2016

30751_dirs_2016-08-17_6bc0d626-9a73-4f7f-ac8f-cae886d385c9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2016-08-09

Reporting Person: Hooper Suzanne Sawochka (EVP & General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	36699	Direct

Footnotes

F1: The Form 4 that was filed on August 11, 2016 correctly stated the Reporting Person's transactions and end-of-period holdings and is being amended solely to attach the Power of Attorney.